PASSIvation of Vulnerable Plaque With AZD5718 in AcuTe Coronary syndromE
A phase 2 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 243 participants.
Also called NCT04601467
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 243 participants
- Sponsor
- Registry
-
NCT04601467
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- New Zealand, Singapore
- Registry status
- Terminated
Technical summary
Registry record NCT04601467. Randomized; triple masking; primary purpose treatment. Start 2021-07-12 (actual); primary completion 2024-05-27 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- PASSIvation of Vulnerable Plaque With AZD5718 in AcuTe Coronary syndromE
- Acronym
- PASSIVATE
- Condition
- Acute Coronary Syndrome
- Intervention (Drug)
- AZD5718
- Intervention (Drug)
- Placebo
- Lead sponsor
- National University Heart Centre, Singapore
- Collaborator
- AstraZeneca
- Collaborator
- University of Otago
Record details
- Record id
cardio:ct-nct04601467- Content hash
9615d99d52380dd44ce760890ebf8a4e4d91f337d0511bde959cfb887d6967b7